Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep 3;15(1-2):122–133. doi: 10.1080/15592294.2019.1656155

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Informa UK Limited, trading as Taylor & Francis Group

PMC Copyright notice

Figure 5. — Clinical relevance of DHRS2 in OC. A and B. Immunohistochemistry (IHC) was performed to analyse the protein expression level of DHRS2 in tissue microarrays. A. Representative images of IHC performed on normal ovarian and ovarian cancer tissues. B. Box plot showing DHRS2 expression levels among OC tissue grades. C. The data from the CSIOVDB database showed DHRS2 expression levels among different OC tissue grades. D. Immunohistochemistry (IHC) was performed on tissues from 20 OC patients who had received regular cisplatin-based chemotherapy to analyse the correlation between DHRS2 and chemotherapeutic efficacy. E. The data from the CSIOVDB database showed the correlations between DHRS2 and clinical responses in OC patients. F. The TCGA data from the UCSC Xena database showed the correlations between DHRS2 and chemotherapeutic efficacy in OC patients. G and H. Kaplan–Meier survival curves are shown for relapse free survival (G) and overall survival time (H).